<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Tanabe H</submitter><funding>Fujifilm Corporation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Japan Society for the Promotion of Science</funding><pubmed_abstract>Abnormal accumulation of tau proteins in the brain is a hallmark of neurodegenerative diseases such as Alzheimer's disease and is closely linked with neuronal cell death. Tau accumulation is a prominent therapeutic target for Alzheimer's disease, since tau accumulation correlates well with the disease progression, and tau-targeting drugs hold potentials to halt the disease progression. Given the differential response of human and mouse neuronal cells, there is a critical need for a human cellular platform to quickly screen for tau-related neurodegenerative disease therapeutics. However, inducing rapid, tau-dependent neuronal cell death in human models remains challenging. In this study, we established a human cellular model capable of inducing tau aggregation-dependent neuronal cell death </pubmed_abstract><journal>Aging brain</journal><pagination>100136</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12018045</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tau aggregation induces cell death in iPSC-derived neurons.</pubmed_title><pmcid>PMC12018045</pmcid><pubmed_authors>Tanabe H</pubmed_authors><pubmed_authors>Okano H</pubmed_authors><pubmed_authors>Maeda S</pubmed_authors><pubmed_authors>Endoh-Yamagami S</pubmed_authors><pubmed_authors>Sano E</pubmed_authors><pubmed_authors>Sakai N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tau aggregation induces cell death in iPSC-derived neurons.</name><description>Abnormal accumulation of tau proteins in the brain is a hallmark of neurodegenerative diseases such as Alzheimer's disease and is closely linked with neuronal cell death. Tau accumulation is a prominent therapeutic target for Alzheimer's disease, since tau accumulation correlates well with the disease progression, and tau-targeting drugs hold potentials to halt the disease progression. Given the differential response of human and mouse neuronal cells, there is a critical need for a human cellular platform to quickly screen for tau-related neurodegenerative disease therapeutics. However, inducing rapid, tau-dependent neuronal cell death in human models remains challenging. In this study, we established a human cellular model capable of inducing tau aggregation-dependent neuronal cell death </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-02T18:25:17.829Z</modification><creation>2026-04-18T03:14:00.067Z</creation></dates><accession>S-EPMC12018045</accession><cross_references><pubmed>40276591</pubmed><doi>10.1016/j.nbas.2025.100136</doi></cross_references></HashMap>